Aristotle Atlantic Partners, LLC released its Q3 2025 investor letter, noting a US equity market rally with the S&P 500 Index up 8.12%. The composite returned 7.22% gross of fees in the quarter, underperforming the S&P 500 Index. Check the fund’s top five holdings for insights into its best picks in 2025.

In Q3 2025, Adaptive Biotechnologies Corporation (NASDAQ: ADPT) was highlighted by Aristotle Atlantic Core Equity Strategy. The company, with a one-month return of -20.92%, has seen shares gain 201.28% over the last 52 weeks. ADPT stock closed at $14.10 on November 14, 2025, with a market cap of $2.159 billion.

Aristotle Atlantic Core Equity Strategy praised Adaptive Biotechnologies Corporation (NASDAQ: ADPT) in its Q3 2025 letter, citing momentum in MRD testing and better-than-expected earnings. The company’s ASP increases are driving growth. ADPT was not among the 30 Most Popular Stocks Among Hedge Funds, with 26 hedge funds holding it in Q2. Consider other AI stocks for greater upside potential.

Read more at Yahoo Finance: Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3